Concepedia
Statistics
Publications
27
Citations
2.7K
H-Index
22
Active since
1991
Affiliations
AstraZeneca (United Kingdom)(Current)
University of Oxford
AstraZeneca (France)
AstraZeneca (United States)
University of Nottingham
Andrew Mortlock is an author at AstraZeneca (United Kingdom) specializing in organic chemistry, natural sciences, and chemistry.
Publications per year
1991–2023
Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores
Claire Ditchfield, Victoria Johnson, Anthony Tighe et al. · The Journal of Cell Biology · 2003 · 1.2K citations · Full text
Life Sciences, Cell Biology, Molecular Biology +17
AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis
Robert W. Wilkinson, Rajesh Odedra, Simon P. Heaton et al. · Clinical Cancer Research · 2007 · 357 citations · Full text
Medicine, Oncology, Pharmacology +16
Discovery, Synthesis, and <i>in Vivo</i> Activity of a New Class of Pyrazoloquinazolines as Selective Inhibitors of Aurora B Kinase
Andrew Mortlock, Kevin M. Foote, Nicola M. Heron et al. · Journal of Medicinal Chemistry · 2007 · 274 citations · Full text
Medicine, Oncology, Pharmacology +13
SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors
Nicola M. Heron, Malcolm Anderson, David P. Blowers et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 125 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +16
Discovery of Novel and Potent Thiazoloquinazolines as Selective Aurora A and B Kinase Inhibitors
Frédéric Jung, Georges Pasquet, Christine Lambert‐van der Brempt et al. · Journal of Medicinal Chemistry · 2006 · 92 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
1–5 of 27